Trials / Sponsors / Erimos Pharmaceuticals
Erimos Pharmaceuticals
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia Leukemias, Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL) | Phase 1 | 2007-08-01 |
| Terminated | A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tu Refractory Solid Tumors, Lymphoma | Phase 1 | 2007-05-01 |
| Completed | Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors Cancer | Phase 1 | 2005-12-01 |
| Completed | A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia Cervical Intraepithelial Neoplasia | Phase 1 / Phase 2 | 2004-11-01 |
| Completed | Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck Head and Neck Neoplasms | Phase 1 | 2003-01-01 |